Researchers including those at the University of Tokyo have made a surprising discovery hiding in people’s mouths: Inocles, giant DNA elements that had previously escaped detection. These appear to play a central role in helping bacteria adapt to the constantly changing environment of the mouth. The findings provide fresh insight into how oral bacteria colonize and persist in humans, with potential implications for health, disease and microbiome research.

A University of Cambridge study of adult mammary gland development has revealed new genes involved in breastfeeding, and provided insights into how genetic changes may be associated with breastfeeding disorders and postpartum breast cancers.

OKLAHOMA CITY – University of Oklahoma Health Campus Ph.D. candidate Alex Arreola has earned a prestigious National Cancer Institute grant – one of only 15 awarded nationwide this year. He is the first trainee from OU Health Stephenson Cancer Center to receive the honor, which will support his doctoral and postdoctoral training in experimental oncology and pathology.

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers devoted to patient care, research, and education—hosts a Policy Summit exploring where artificial intelligence (AI) currently stands as a tool for improving cancer care, and where it may be going in the future. 

BUFFALO, NY — September 9, 2025 — A new case report was published in Volume 12 of Oncoscience on September 4, 2025, titled “Adult fibrosarcoma: From clinical challenges to cutting-edge innovations.”

A promising cancer therapy developed by Georgia State University researchers and biotech startup Da Zen Theranostics is taking a major step forward, entering Phase 2 clinical trials. The treatment, which harnesses targeted radiation to destroy tumors with precision, could mark a turning point in how cancer is treated — and in the lives of patients who need better options.

Emphysema detected on baseline low-dose chest CT in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, COPD, and cardiovascular disease within a 25-year follow-up period.